MedPath

Implementation of a pilot cervical cancer screening program based on single visit approach and improving capacity for breast cancer early diagnosis in Benin, Chad, Cote d’Ivoire, Senegal and Cameroo

Not Applicable
Conditions
Cervical cancer
Cancer
Malignant neoplasm of cervix uteri
Registration Number
ISRCTN21518741
Lead Sponsor
International Agency For Research On Cancer
Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36070534/ (added 14/09/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
19552
Inclusion Criteria

All consenting women aged between 30 to 49 years (or 25-49) attending the primary health centers for different reasons will be offered VIA opportunistically

Exclusion Criteria

1. Pregnant women
2. Women suffering from debilitating illnesses
3. Diagnosis of or previous invasive cervical cancer
4. Those screened for cervical cancer within the last 36 months

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath